|
510(k) Flow Chart Explains U.S. FDA Review Process
Concerns about the future of the U.S. Food and Drug Administration’s (FDA) 510(k) process appear to have been put to rest with the recent issuance of a draft guidance on evaluating substantial equivalence in 510(k)s.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives